150 related articles for article (PubMed ID: 32960876)
21. Umeclidinium (Incruse Ellipta) for COPD.
Durigan RC; Niedermier V
Am Fam Physician; 2017 Jan; 95(2):120-121. PubMed ID: 28084712
[No Abstract] [Full Text] [Related]
22. Assessment of physical functioning and handling of tiotropium/olodaterol Respimat
Steinmetz KO; Abenhardt B; Pabst S; Hänsel M; Kondla A; Bayer V; Buhl R
Int J Chron Obstruct Pulmon Dis; 2019; 14():1441-1453. PubMed ID: 31308649
[TBL] [Abstract][Full Text] [Related]
23. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.
Fuso L; Mores N; Valente S; Malerba M; Montuschi P
Curr Med Chem; 2013; 20(12):1477-95. PubMed ID: 23409722
[TBL] [Abstract][Full Text] [Related]
24. Fixed-dose combination of umeclidinium and vilanterol for patients with chronic obstructive pulmonary disease: A systematic review.
Ramadan WH; Al Masri S; Rizk J
Clin Respir J; 2019 Nov; 13(11):663-673. PubMed ID: 31389190
[TBL] [Abstract][Full Text] [Related]
25. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
Welsh EJ; Cates CJ; Poole P
Cochrane Database Syst Rev; 2010 May; (5):CD007891. PubMed ID: 20464758
[TBL] [Abstract][Full Text] [Related]
26. Tiotropium Respimat Is Effective for the Treatment of Asthma at a Dose Lower Than That for Chronic Obstructive Pulmonary Disease.
Chin SJ; Durmowicz AG; Chowdhury BA
Ann Am Thorac Soc; 2016 Feb; 13(2):173-9. PubMed ID: 26650145
[TBL] [Abstract][Full Text] [Related]
27. Effect of switching tiotropium HandiHaler® to Respimat® Soft Mist™ Inhaler in patients with COPD: the difference of adverse events and usability between inhaler devices.
Asakura Y; Nishimura N; Maezawa K; Terajima T; Kizu J; Chohnabayashi N
J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):41-5. PubMed ID: 22691112
[TBL] [Abstract][Full Text] [Related]
28. Olodaterol: first global approval.
Gibb A; Yang LP
Drugs; 2013 Nov; 73(16):1841-6. PubMed ID: 24158691
[TBL] [Abstract][Full Text] [Related]
29. The Ellipta
Jones TL; Neville DM; Chauhan AJ
Ther Deliv; 2018 Feb; 9(3):169-176. PubMed ID: 29424288
[TBL] [Abstract][Full Text] [Related]
30. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[TBL] [Abstract][Full Text] [Related]
31. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.
Larsson K; Janson C; Lisspers K; Jørgensen L; Stratelis G; Telg G; Ställberg B; Johansson G
J Intern Med; 2013 Jun; 273(6):584-94. PubMed ID: 23495860
[TBL] [Abstract][Full Text] [Related]
32. Umeclidinium/vilanterol: a review of its use as maintenance therapy in adults with chronic obstructive pulmonary disease.
Blair HA; Deeks ED
Drugs; 2015 Jan; 75(1):61-74. PubMed ID: 25398674
[TBL] [Abstract][Full Text] [Related]
33. UK-specific cost-effectiveness of tiotropium + olodaterol fixed-dose combination versus other LAMA + LABA combinations in patients with COPD.
Tebboth A; Ternouth A; Gonzalez-Rojas N
Clinicoecon Outcomes Res; 2016; 8():667-674. PubMed ID: 27853383
[TBL] [Abstract][Full Text] [Related]
34. Breo Ellipta: An Inhaled Fluticasone/ Vilanterol Combination for COPD.
Med Lett Drugs Ther; 2013 Sep; 55(1424):69-71, 45-8. PubMed ID: 26839934
[No Abstract] [Full Text] [Related]
35. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey.
Price D; Keininger DL; Viswanad B; Gasser M; Walda S; Gutzwiller FS
Int J Chron Obstruct Pulmon Dis; 2018; 13():695-702. PubMed ID: 29520137
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological management--inhaled treatment.
Currie GP; Lipworth BJ
BMJ; 2006 Jun; 332(7555):1439-41. PubMed ID: 16777889
[No Abstract] [Full Text] [Related]
37. Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
Nannini L; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2003; (4):CD003794. PubMed ID: 14583994
[TBL] [Abstract][Full Text] [Related]
38. Tiotropium Respimat inhaler and the risk of death in COPD.
Wise RA; Anzueto A; Cotton D; Dahl R; Devins T; Disse B; Dusser D; Joseph E; Kattenbeck S; Koenen-Bergmann M; Pledger G; Calverley P;
N Engl J Med; 2013 Oct; 369(16):1491-501. PubMed ID: 23992515
[TBL] [Abstract][Full Text] [Related]
39. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
Nannini L; Cates CJ; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2004; (3):CD003794. PubMed ID: 15266502
[TBL] [Abstract][Full Text] [Related]
40. Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide as a combination therapy for chronic obstructive pulmonary disease.
Kupczyk M; Kuna P
Expert Rev Respir Med; 2019 Jan; 13(1):5-11. PubMed ID: 30463457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
